Aprea Therapeutics, Inc. (APRE): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-20, first reflected in a filing dated 2023-03-30. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

8.19M
As of 2025-12-31
12.39M
As of 2026-06-30
21.19M2018-12-31: 1.16M2019-12-31: 21.02M2020-12-31: 21.19M2021-12-31: 1.09M2022-12-31: 2.66M2023-12-31: 3.74M2024-12-31: 5.48M2025-12-31: 8.19M8.19M
2018-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-318.19M+49.5%2026-03-16, Balance as of period end
2024-12-315.48Mn/c2026-03-16, Balance as of period end
2023-12-313.74M+40.7%2025-03-25, Balance as of period end
2022-12-312.66M+142.9%2024-03-26, Balance as of period end
2021-12-311.09Mn/c2023-03-30, Balance as of period end
2020-12-3121.19M+0.8%2022-03-15, Balance as of period end
2019-12-3121.02Mn/m2021-03-16, Balance as of period end
2018-12-311.16Mn/a2020-03-27, Balance as of period end